Clinical Trial: A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072793) titled 'A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe' on Nov. 15, 2024.

Brief Summary: The purpose of this study is to understand how COVID-19 affects people's ability to work and to calculate the costs associated with loss of work.

The study compares two groups of participants who are confirmed to have mild-to moderated COVID-19 and who have high chances of the disease becoming severe.

The two groups are:

People who took the antiviral medication nirmatrelvir-ritonavir (also called Paxlovid) People who were eligible to recei...